Silence Therapeutics reported $13.61M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AstraZeneca USD 32.57B 1.95B Mar/2026
Autolus Therapeutics Ltd USD 63.6M 9.84M Mar/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Novartis USD 31.37B 4.1B Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Silence Therapeutics USD 13.61M 3.77M Dec/2025